View
222
Download
0
Embed Size (px)
Citation preview
1
Davis MDCH 5210 - Antihistamines, 2006
Histamine receptors –
H1- Allergic responses. Watery eyes, congestion, etc. from allergies. Anaphylaxis – bronchial larynx constriction.Skin allergic response – reddening, rashes, welts.Edema from injury.
H2 – Gastric secretion. Important for ulcer treatment and acid reflux
H3 – ? CNS receptors. There are also H1 receptors in the CNS.
Antihistamines are also used for motion sickness. In general their antimuscarinic effects are similar to that of scopolamine, although weaker.
Antihistamines
2
Davis MDCH 5210 - Antihistamines, 2006
HNN
NH2
H
HNN
NH2
H
CH3
HNN
NH2
H3
C
HNN
NH2
H
H
H3
C
(R) α - methyl histamine
H3
Agonist
4-methylhistamine
H2
Agonist
2- methyl histamine
H1
Agonist
Histamine
Histamine Agonists
3
Davis MDCH 5210 - Antihistamines, 2006
Ethylenediamines
X
Ar1
Ar2
(CH2
)n N
CH3
CH3
N
N
CH3
CH3
N
N
HN
SAR Prototype
Phenbenzamine
Antazoline
Antihistamines – H1 Blockers
4
Davis MDCH 5210 - Antihistamines, 2006
H
O
N
CH3
CH3
R1
N
CH3
CH3
O
SAR Prototype
R1
is a small group like H, CH3
,OCH3
Diphenhydramine
(Benadryl)
Aminoalkylethers
O
NCH3
Cl
Cl
N
N
CH3
Cl
O
N
CH3
CH3
Diphenylpyraline
Meclizine
Good H1
antagonist, but also
good antimuscarinic
Clemastine
(Tavist)
Piperazine/N-heterocycle Series
Antihistamine SAR
5
Davis MDCH 5210 - Antihistamines, 2006
Antihistamines are stereospecific. Anumber of new, single isomer drugs arebeing developed.
Antihistamines are structurally similarTo SSRIs and to antipsychotics. NoticeThe subtle difference between fluoxetineAnd several antihistamines.
Stereo- and regioisomers
6
Davis MDCH 5210 - Antihistamines, 2006
Alkyl Amines
Long Duration, less sedation than ethylenediamines, ethanolamines. The “next best thing” until the “2nd generation” were developed.
N
N
CH3
CH3
R
N
N
CH3
N
H3C
Cl
Pyrrobutamine (Pyronil)R = H PheniramineR = Cl Chlorpheniramine (Chlortrimeton)R = Br Brompheniramine (Dimetane)
Triprolidine (Actidil)
NCH3
CH3N
Dimethindene (Forhistal)
N CH3
Phenindamine (Nolahist)
7
Davis MDCH 5210 - Antihistamines, 2006
A Cl at the 2-position weakens H1 activity relative to antimuscarinic activity and D2 antagonist activity
N
NCH3
N
S
CH2
CH2
N(CH3
)2
N
S
CH2
CHN(CH3
)2
CH3
Mebhydrolin
Fenthazine
Promethazine
(Pheregan)
N
S
CH
2
CH
2
CH
2
N(CH
3
)
2
Cl
Chlorpromazine
N
N
N
N
OCH3
H
F
Astemizole
(Hismanal)
Rigid Analogs (I)
8
Davis MDCH 5210 - Antihistamines, 2006
Cl
O OCH2CH3
N
N
CH3
N
S
Cl
N
N
H
Primethixene Loratadine (Claritin) Desloratadine (Clarinex)
Rigid Analogs (II)
9
Davis MDCH 5210 - Antihistamines, 2006
Hismanal was FDA approved in 1988 as an antihistamine for allergy and hay fever symptom relief. The FDA first warned consumers and healthcare providers of new safety information regarding Hismanal February 9, 1998 due to the risk of death, cardiovascular adverse events, anaphylaxis, and serious drug interactions.
In addition, Hismanal labeling was changed to stress avoiding the use of Hismanal in combination with certain other medications and for liver disorder patients to completely avoid its' use.
After a series of labeling changes and warnings Hismanal was recalled on June 21, 1999.
N
N
N
N
OCH3
H
F
Astemizole
(Hismanal)
Astemizole
10
Davis MDCH 5210 - Antihistamines, 2006
Terfenadine was discontinued when it became apparent that there was a high frequency of heart arrythmia associated with the drug. Fexofenadine is a metabolite and is the activated form responsible for antihistamine activity. In patients with compromised liver metabolism, or when the presence of other drugs limited the metabolism of terfenadine, persistent levels resulted in the observed arrythmias. Therefore, the fexofenadine replaced terfenadine (1997).
Ventricular Arrythmias are not good!
N
OH
O
Cl
F
Haloperidol (Haldol)
Prototype butyrophenone antipsychotic
10x Chlorpromazine
Antihistamines “related” to butyrophenones
11
Davis MDCH 5210 - Antihistamines, 2006
N
OH
OH
N
OH
COOH
OH
[OX]
Terfenadine
(Seldane)
Fexofenadine
(Allegra)
N N
H
O
Cl OH
O
Cetirizine
(Zyrtec)
Butyrophenone-like structures
12
Davis MDCH 5210 - Antihistamines, 2006
Allegra Propaganda - www.allegra.com
13
Davis MDCH 5210 - Antihistamines, 2006
If you haven't gotten the relief you want from Claritin ィ (loratadine), Clarinex ィ (desloratadine), or Allegra ィ (fexofenadine HCl), ask your doctor if ZYRTEC is right for you.
www.zyrtec.com
14
Davis MDCH 5210 - Antihistamines, 2006
ON
CH3
CH3
N
N
CH3
Cl
N
Cl
NH
N
NOCl
OH
O
DiphenhydramineMeclizine
DesloratadineCetirizine
Linking the first generation with Non-sedative Antihistamines.
Big Picture - Bottom Line
Structural Summary
15
Davis MDCH 5210 - Antihistamines, 2006
Anti-emetics
16
Davis MDCH 5210 - Antihistamines, 2006
SyntheticTropane Alkaloids
Anti-emetic Table
17
Davis MDCH 5210 - Antihistamines, 2006
Press Release: The 2005 Nobel Prize in Physiology or Medicine3 October 2005
The Nobel Assembly at Karolinska Institutet has today decided to award
The Nobel Prize in Physiology or Medicine for 2005
jointly to
Barry J. Marshall and J. Robin Warren
for their discovery of
"the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease”
2005 Nobel Prize
18
Davis MDCH 5210 - Antihistamines, 2006
Gastric Secretions
Cell Biology
19
Davis MDCH 5210 - Antihistamines, 2006
Gastric receptors are pharmacologically distinct. The classic H1 antagonists don’t interact with H2 receptors. Antihistamines are an important treatment for gastric disorders; antacids, ulcer treatment, acid-reflux disease.
HNN
NH2
H
NNH
NH2
H
Basic Heterocycle Flexible Chain Polar, Neutral Group
SAR for Histamine H2
Receptor Antagonists
NT
Tautomer is preferred for H2
H2 Histamine antagonists.
20
Davis MDCH 5210 - Antihistamines, 2006
HH
S
CH3
NNH
NHN
H3C
HH
S
CH3
NNS
NHN
CN
H3C
HH
N
CH3
NNS
NHN
CH2N(CH3)2
HH
CHNO2
CH3
NNS
O
C(NH2)2N
NSO2NH2
NH2S
NS
Burimamide(Non-selective)
Metiamide(H2 Selective)
Cimetidine(Tagamet)
Ranitidine(Xantac)
Famotidine(Pepcid)
H2 Histamine antagonists. - Structures